---
title: 'Immune checkpoint inhibitors-associated vasculitis: a heterogeneous condition
  with possible severe disease course'
date: '2024-12-23'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39714261/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20241223171108&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'CONCLUSION: ICI-associated vasculitis are rare, heterogeneous, but can
  be severe requiring urgent multidisciplinary management with aggressive ...'
disable_comments: true
---
CONCLUSION: ICI-associated vasculitis are rare, heterogeneous, but can be severe requiring urgent multidisciplinary management with aggressive ...